Oklo and Ulta Fell Overnight — They Are Opposite Trades

The overnight tape pairs them like twins: Oklo down roughly 10%, Ulta Beauty down nearly 4%, two more names bleeding in the night session. Pairing is what a headline does. It is also a trap. Oklo is a pre-revenue nuclear startup in the middle of unwinding a hype-fueled rally; Ulta is a profitable beauty retailer that just beat earnings and raised its full-year guidance. The percentage beside each ticker says almost nothing about what to do next. The factor stack behind each one says a great deal, and it points in opposite directions.

Oklo: the frontal valley was never a "cheap" rating

The first thing the factor screen does with Oklo is come up empty. There is no valuation multiple to compare, because the company has no earnings — its trailing P/E is negative, and trailing operating cash flow is negative too. That is not a gap in the data; it is the definition of the situation. A stock cannot be graded cheap or rich against sector peers when there is no profit line to anchor the grade.

What the numbers do show is how far the story has unwound. Oklo sits near a 52-week low, roughly 81% below its high, and the decline is spread across the year rather than one bad night. It trades under both its 50-day and 200-day moving averages, with an RSI in the high 30s — momentum that, if this were an earnings-bearing name, would read as a D-minus grade. The de-rating has company: NuScale, its fellow pre-revenue reactor developer, also carries a negative P/E, and profitable nuclear supplier BWX Technologies trades at a real 38x multiple and a low-single-digit yield. The comparison set just makes the point that Oklo's ~$7 billion market cap is being priced entirely on story and cash, not on earnings it does not yet have.

The balance sheet is where the honest tension lives. Oklo holds close to $1.6 billion in cash against roughly $276 million of trailing free cash flow burn — comfortable for now. But it just disclosed a new at-the-market equity offering of up to $1 billion, replacing a prior $1 billion program that had been fully used. That is the tell. A pre-revenue developer does not raise to pay dividends; it raises to stretch its runway, and the cost is paid in existing shareholders' ownership. AInvest's aggregate signal still labels Oklo a Buy, yet its own composite fundamental score sits near zero — the screen has nothing to score. In portfolio terms this is a speculative sleeve holding only, sized for the possibility that fine things happen and cut the moment the story loses its momentum. The number to watch is not today's close; it is the share count.

Ulta: a dip on top of an improving report card

Ulta is the opposite problem, because here the factors grade cleanly. The most recent quarter was a beat-and-raise: second-quarter-fiscal-2026 earnings of $6.55 per share topped the $6.21 consensus, net sales rose 8.9% to about $3.0 billion, comparable sales grew 3.8%, and management lifted its full-year EPS range to $28.70–29.00 while boosting its buyback authorization to $1.8 billion. That is a growth and profitability stack most of retail would trade for: roughly 11% year-over-year revenue growth, a 12%-plus operating margin, return on invested capital in the low 40s, return on equity near 46%, and a balance sheet with modest debt.

The valuation still fits rather than stretches. At around $548, Ulta trades near 19 times trailing earnings and roughly 12 times EV/EBITDA — pricey in absolute terms, but in line with what a compounder with that margin and return profile should command, and a far cry from the market-cap-to-narrative math that props up Oklo. Momentum is neutral rather than broken: the stock is above its 50-day average, just below its 200-day, with a middling RSI. The near-4% slide was profit-taking after a run, not a thesis breaking — nothing in the release accounts for a decline of that size.

The night-session headline reads two falling stocks as one story. The factor stacks read them as two different decisions. Oklo is a bet that a story and a stock count keep working, funded by dilution; Ulta is a quality grower whose price dips onto improving reported fundamentals. In a barbell, they are not even in the same sleeve. When uncertainty rises, the disciplined response is structure, not conviction: a small, clearly-capped position in the story name if you want the lottery ticket at all, and the quality cash-flow business as the base. One overnight percentage drop does not change either verdict — and that indifference, not the red arrows, is the entire point of running the screen in the first place.